dromlakhani/md2skill/endo-ace-arb-ccb-htn
Claude Code and agent skill by dromlakhani/md2skill
- community
Checking that the SKILL.md file is still in the repository.
Recommends ACE inhibitors, ARBs, or calcium channel blockers as first-line hypertension therapy rather than β‑adrenergic blockers in obese patients with type 2 diabetes. Triggers include when a clinician asks, 'What antihypertensive should I start for this obese patient with T2DM to avoid weight gain?' or 'Should I avoid β‑blockers in this patient with diabetes and hypertension?'
Install
npx vskill@latest install dromlakhani/md2skill/endo-ace-arb-ccb-htnSKILL.md
The same SKILL.md was published earlier as majiayu000/claude-skill-registry-data/endo-ace-arb-ccb-htn.
Prefer ACE/ARB/CCB over β‑blockers for hypertension in T2DM obese
STEP 1 — Gather Information
Confirm diagnosis of type 2 diabetes, obesity (BMI ≥ 30 kg/m² or BMI ≥ 27 kg/m² with comorbidity), and presence of hypertension; assess for contraindications to ACEI/ARB/CCB (pregnancy, bilateral renal artery stenosis, hyperkalemia, angioedema history) and for compelling β‑blocker indications (HFrEF, post‑MI, angina).
STEP 2 — Rule In / Rule Out
If a compelling β‑blocker indication exists (e.g., HFrEF, recent MI), consider β‑blocker; otherwise, rule out β‑blocker as first‑line and proceed to ACE/ARB/CCB selection.
STEP 3 — Classify or Stratify
Choose agent based on comorbidities: ACEI or ARB preferred if albuminuria, CKD, or heart failure with preserved EF; CCB preferred if edema risk is low and patient needs avoidance of cough/hyperkalemia; avoid ACEI/ARB in pregnancy or bilateral stenosis.
STEP 4 — Decide
Initiate the selected ACEI, ARB, or CCB at low dose, titrate to target BP; document avoidance of β‑blocker unless a compelling indication arises later.
Clinical Guardrails / Mimics / Pitfalls
Do not use β‑blockers solely for hypertension in obese T2DM due to risk of weight gain, worsened insulin resistance, and masking hypoglycemia symptoms; avoid non‑selective β‑blockers without vasodilating properties; do not combine ACEI and ARB; monitor for ACEI‑related cough or angioedema, ARB‑related hyperkalemia, and CCB‑related peripheral edema.
Concrete Clinical Example
A 58‑year‑old woman with T2DM, BMI 34 kg/m², BP 152/96 mmHg, no heart failure or post‑MI, is started on lisinopril 10 mg daily after confirming no contraindications; β‑blocker is avoided to limit weight gain and insulin resistance.
Source: Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2014-3415
Security
- Security scanPassed, 90 of 100Pattern checks on the skill's files.
- Model reviewPassed
Quality evaluation
- Task evaluationNot runNo evaluation yet. Run one in Skill Studio.
Source
- SKILL.md in the repositoryCheckingskills/endocrinology/obesity/endo-ace-arb-ccb-htn/SKILL.md
Popularity
- Repository stars
- 12
- Repository forks
- 1
- 7-day trend score
- 18
Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.
Works with
Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.
- Claude Code
- Cursor
- GitHub Copilot
- Windsurf
- Codex
- Gemini CLI
- Cline
- Amp
- Roo Code
- Goose
- Continue
- Kilo Code
- Junie
- Trae
- OpenHands
- Qwen Code
- AI Agent
- Tabnine Chat
- Sourcegraph Cody
- Amazon Q
- Firebase Genkit
- Sweep
- Devin
- Phind
- Mentat
- Claude Desktop
- Aider
- GPT Pilot
- Plandex
- bolt.new
- v0
- Replit Agent
- Anse
- TypingMind
- BetterChatGPT
- LibreChat
- Warp AI
- Pieces
- Fig AI
Embed badge
[](https://verified-skill.com/skills/dromlakhani/md2skill/endo-ace-arb-ccb-htn)